Mirae Asset Global Investments
JAZZ icon

Mirae Asset Global Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mirae Asset Global Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$676K Sell
2,806
-405
-13% -$88.7K ﹤0.01% 936
2026
Q1 		$607K Buy
3,211
+258
+9% +$45.1K ﹤0.01% 905
2025
Q4 		$502K Buy
2,953
+608
+26% +$93.2K ﹤0.01% 995
2025
Q3 		$309K Sell
2,345
-37
-2% -$4.44K ﹤0.01% 1072
2025
Q2 		$253K Buy
2,382
+350
+17% +$38K ﹤0.01% 1021
2025
Q1 		$250K Buy
2,032
+17
+0.8% +$2.22K ﹤0.01% 1013
2024
Q4 		$251K Sell
2,015
-461
-19% -$54.3K ﹤0.01% 1020
2024
Q3 		$275K Buy
2,476
+325
+15% +$35.6K ﹤0.01% 1036
2024
Q2 		$230K Sell
2,151
-72,808
-97% -$8M ﹤0.01% 1031
2024
Q1 		$9.04M Sell
74,959
-10,127
-12% -$1.24M 0.02% 679
2023
Q4 		$10.5M Sell
85,086
-10,834
-11% -$1.35M 0.02% 628
2023
Q3 		$12.4M Sell
95,920
-1,594
-2% -$212K 0.03% 546
2023
Q2 		$12.1M Sell
97,514
-8,928
-8% -$1.2M 0.03% 565
2023
Q1 		$15.2M Sell
106,442
-6,266
-6% -$927K 0.04% 471
2022
Q4 		$18M Sell
112,708
-4,586
-4% -$672K 0.05% 411
2022
Q3 		$15.6M Sell
117,294
-2,258
-2% -$343K 0.04% 422
2022
Q2 		$18.7M Sell
119,552
-59,694
-33% -$9.19M 0.05% 405
2022
Q1 		$27.9M Sell
179,246
-32,092
-15% -$4.66M 0.06% 339
2021
Q4 		$26.9M Sell
211,338
-8,804
-4% -$1.16M 0.06% 379
2021
Q3 		$28.7M Sell
220,142
-8,004
-4% -$1.21M 0.07% 312
2021
Q2 		$40.5M Buy
228,146
+225,649
+9,037% +$39.1M 0.11% 232
2021
Q1 		$410K Buy
2,497
+204
+9% +$33.6K ﹤0.01% 1351
2020
Q4 		$378K Buy
2,293
+650
+40% +$96.8K ﹤0.01% 1391
2020
Q3 		$234K Buy
+1,643
New +$204K ﹤0.01% 1394
2018
Q4 		– Sell
-27,213
Closed -$4.58M – 1314
2018
Q3 		$4.58M Sell
27,213
-24
-0.1% -$4.13K 0.03% 436
2018
Q2 		$4.69M Sell
27,237
-64
-0.2% -$10.5K 0.06% 187
2018
Q1 		$4.12M Buy
27,301
+8,456
+45% +$1.24M 0.05% 214
2017
Q4 		$2.54M Sell
18,845
-6,351
-25% -$881K 0.03% 315
2017
Q3 		$3.69M Sell
25,196
-264
-1% -$39.9K 0.07% 213
2017
Q2 		$3.96M Buy
25,460
+12,473
+96% +$1.91M 0.07% 179
2017
Q1 		$1.89M Buy
+12,987
New +$1.69M 0.04% 297
2016
Q3 		– Sell
-2,282
Closed -$322K – 560
2016
Q2 		$322K Buy
2,282
+17
+0.8% +$2.51K 0.01% 448
2016
Q1 		$296K Buy
2,265
+107
+5% +$13.3K 0.01% 417
2015
Q4 		$303K Buy
2,158
+609
+39% +$84.4K 0.01% 393
2015
Q3 		$206K Sell
1,549
-8
-0.5% -$1.38K 0.01% 412
2015
Q2 		$274K Buy
1,557
+105
+7% +$18.9K 0.01% 419
2015
Q1 		$251K Sell
1,452
-6,796
-82% -$1.17M 0.01% 425
2014
Q4 		$1.35M Sell
8,248
-181
-2% -$30K 0.05% 224
2014
Q3 		$1.35M Buy
8,429
+2,205
+35% +$339K 0.05% 220
2014
Q2 		$915K Buy
6,224
+215
+4% +$29.8K 0.02% 283
2014
Q1 		$833K Sell
6,009
-3,265
-35% -$491K 0.02% 281
2013
Q4 		$1.17M Buy
9,274
+135
+1% +$14K 0.05% 256
2013
Q3 		$841K Sell
9,139
-6,896
-43% -$556K 0.04% 280
2013
Q2 		$1.1M Buy
+16,035
New +$980K 0.06% 232

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Mirae Asset Global Investments's JAZZ Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q2 2026, selling an estimated $88.7K and leaving 2,806 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Mirae Asset Global Investments first reported a position in JAZZ in Q2 2013 and has held it in 44 quarters since. The position peaked at $40.5M in Q2 2021. 303 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Mirae Asset Global Investments held 2,806 shares of Jazz Pharmaceuticals worth $676K as of Q2 2026.
  • Mirae Asset Global Investments sold 405 Jazz Pharmaceuticals shares in Q2 2026, an estimated $88.7K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #936 holding.
  • Mirae Asset Global Investments first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
  • Mirae Asset Global Investments's Jazz Pharmaceuticals position peaked at $40.5M in Q2 2021.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.